Sale of Caerus Medical to Gleamer

THM Capital Advisory advises the shareholders of Caerus Medical in connection with the sale of the company to Gleamer, an international player in artificial intelligence applied to radiology.
‍

Activity

Caerus Medical is developing an AI software solution to automate and improve the diagnosis of lumbar spine pathologies using MRI, in order to assist radiologists in their diagnosis by providing precision and speed.
‍

Cendants

Shareholders of Caerus Medical, including David Vittecoq (CEO, minority) and France Imageries Territories (majority).
‍

Buyer

Gleamer, specialized in AI for medical imaging, is strengthening its offer by extending its expertise (radiography, CT, breast imaging) to MRI thanks to the integration of Caerus Medical.
‍

Objectives

Accelerate Caerus Medical's commercial growth by relying on Gleamer as a strategic partner.

Strengthen Gleamer's value proposition by adding MRI imaging diagnostics to its offer.

Be part of a strategy to build an AI-assisted diagnosis platform covering a wide range of pathologies.